Molecular modeling comparison of the performance of NS5b polymerase inhibitor (PSI-7977) on prevalent HCV genotypes (Q42988260)

12 November 2017

title

Molecular modeling comparison of the performance of NS5b polymerase inhibitor (PSI-7977) on prevalent HCV genotypes (English)

1 reference

12 November 2017

Abdo A Elfiky

1

0 references

Wael M. Elshemey

object named as

Wael M Elshemey

series ordinal

2

0 references

author name string

Wissam A Gawad

series ordinal

3

1 reference

12 November 2017

Omar S Desoky

series ordinal

4

1 reference

12 November 2017

language of work or name

1 reference

1 January 2013

1 reference

12 November 2017

1 reference

12 November 2017

volume

32

1 reference

12 November 2017

issue

1

1 reference

12 November 2017

page(s)

75-80

1 reference

SCOP database in 2004: refinements integrate structure and sequence family data

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Data growth and its impact on the SCOP database: new developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Characterization of NS3 protease from an Egyptian HCV genotype 4a isolate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

From benzimidazole to indole-5-carboxamide Thumb Pocket I inhibitors of HCV NS5B polymerase. Part 1: indole C-2 SAR and discovery of diamide derivatives with nanomolar potency in cell-based subgenomic replicons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

The design, synthesis and biological evaluations of C-6 or C-7 substituted 2-hydroxyisoquinoline-1,3-diones as inhibitors of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Mechanisms of non-response to antiviral treatment in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Interferon-based therapy of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

SCOP database in 2002: refinements accommodate structural genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Recent advances in drug discovery of benzothiadiazine and related analogs as HCV NS5B polymerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

In vitro selection and characterization of HCV replicons resistant to multiple non-nucleoside polymerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Correlation to protein conformation of Wide-angle X-ray Scatter parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Substrate complexes of hepatitis C virus RNA polymerase (HC-J4): structural evidence for nucleotide import and de-novo initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Current and future hepatitis C therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Mixing the right hepatitis C inhibitor cocktail

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Recent development of therapeutics for chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

VMD: visual molecular dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Hexapeptide functionality of cellulose as NS3 protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Structural and electronic properties of new fullerene derivatives and their possible application as HIV-1 protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Protein structure prediction on the Web: a case study using the Phyre server

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Development of novel therapies for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Protease and helicase activities of hepatitis C virus genotype 4, 5, and 6 NS3-NS4A proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Hepatitis C RNA-dependent RNA polymerase inhibitors: a review of structure-activity and resistance relationships; different scaffolds and mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Mechanism of Activation of PSI-7851 and Its Diastereoisomer PSI-7977

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Antiviral strategies in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Hepatitis C viral life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Structure-based virtual screening, synthesis and SAR of novel inhibitors of hepatitis C virus NS5B polymerase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Resistance to anti-HCV protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Anti-HCV drugs in the pipeline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10930-013-9462-9

Structure-based design of a novel thiazolone scaffold as HCV NS5B polymerase allosteric inhibitors

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23322006

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The mechanism of action of T7 DNA polymerase

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23322006

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

SCOP: a structural classification of proteins database for the investigation of sequences and structures

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23322006

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10930-013-9462-9

1 reference

12 November 2017

1 reference